Serial Number | 79297218 |
Word Mark | REVIVAL |
Filing Date | Monday, May 25, 2020 |
Status | 602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE |
Status Date | Thursday, October 20, 2022 |
Registration Number | 0000000 |
Registration Date | NOT AVAILABLE |
Mark Drawing | 3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
Published for Opposition Date | NOT AVAILABLE |
Description of Mark | The mark consists of the stylized word "REVIVAL" in blue with four curved bands over the letters "VIV" all in a gradient of turquoise, evoking a rainbow; the color white in the mark represents background or transparent areas only and is not claimed as a feature of the mark. |
Goods and Services | Pharmaceutical and medical preparations for the treatment of infectious diseases, inflammatory diseases, kidney diseases, deficiency diseases; diagnostic preparations for medical use; enzyme preparations for medical use; medicines for human use for the treatment of infectious diseases; inflammatory diseases, kidney diseases, deficiency diseases; pharmaceutical drugs for the treatment of inflammatory diseases, kidney diseases, deficiency diseases, infectious diseases; pharmaceutical preparations for the treatment of kidney diseases and disorders |
Indication of Colors claimed | The color(s) blue and turquoise is/are claimed as a feature of the mark. |
Goods and Services | Scientific and technological services, namely, research and design in the field of computer datacenter architecture; scientific, technological and industrial research, namely scientific research, analysis, and reporting in the field of medicine and pharmaceutical preparations for the treatment of infectious diseases, inflammatory diseases, kidney diseases, deficiency diseases, autoimmune diseases; industrial analysis and industrial research in the field of medicine and drug development for treating infectious diseases, inflammatory diseases, kidney diseases, deficiency diseases; product development of technologies, diagnostics, pharmaceuticals, biotechnological research related to enzymatic synthesis; testing, authentication and quality control of pharmaceuticals for others; medical and pharmaceutical research services; provision of medical and scientific research information in the field of pharmaceutical products and clinical trials; drug research services; research and development services for the pharmaceutical and biotechnology industry; pharmaceutical drug development services; pharmaceutical product testing; development of pharmaceutical preparations and drugs; consultancy in the field of pharmaceutical research; clinical and medical research; scientific research for medical purposes, namely conducting clinical trials for others; conducting clinical trials for pharmaceutical products for others |
International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
Class Status Code | 6 - Active |
Class Status Date | Friday, November 6, 2020 |
Primary Code | 005 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
US Class Codes | 100, 101 |
Class Status Code | 6 - Active |
Class Status Date | Friday, November 6, 2020 |
Primary Code | 042 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Party Name | AM-Pharma B.V. |
Party Type | 10 - Original Applicant |
Legal Entity Type | 99 - Other |
Address | NL |
Event Date | Event Description |
Sunday, November 12, 2023 | FINAL DECISION TRANSACTION PROCESSED BY IB |
Friday, October 20, 2023 | FINAL DISPOSITION NOTICE SENT TO IB |
Friday, October 20, 2023 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
Thursday, October 20, 2022 | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND |
Thursday, October 20, 2022 | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND |
Thursday, October 20, 2022 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE |
Sunday, April 24, 2022 | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB |
Thursday, April 7, 2022 | NOTIFICATION OF FINAL REFUSAL EMAILED |
Thursday, April 7, 2022 | FINAL REFUSAL E-MAILED |
Thursday, April 7, 2022 | FINAL REFUSAL WRITTEN |
Wednesday, April 6, 2022 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
Wednesday, April 6, 2022 | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB |
Monday, January 10, 2022 | ASSIGNED TO EXAMINER |
Thursday, May 27, 2021 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Thursday, May 27, 2021 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Thursday, May 27, 2021 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Sunday, December 20, 2020 | REFUSAL PROCESSED BY IB |
Sunday, November 29, 2020 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
Sunday, November 29, 2020 | REFUSAL PROCESSED BY MPU |
Wednesday, November 11, 2020 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
Tuesday, November 10, 2020 | NON-FINAL ACTION WRITTEN |
Tuesday, November 10, 2020 | APPLICATION FILING RECEIPT MAILED |
Friday, November 6, 2020 | ASSIGNED TO EXAMINER |
Friday, November 6, 2020 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Thursday, November 5, 2020 | SN ASSIGNED FOR SECT 66A APPL FROM IB |